Sen. Gregg Plans Clinical Trials Legislation For This Congressional Session
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate Health Committee chairman’s bill would focus on “clinical trial database issues,” while legislation planned by Sens. Kennedy, Dodd and Johnson would be directed at FDA’s authority to disclose clinical trial results, a committee staffer says.
You may also be interested in...
Sen. Grassley Plans Legislation On Independence Of FDA Drug Safety Office
Finance Committee chair acknowledges he does not have enough votes for such legislation but says he is starting the "process of educating my colleagues" and "intends to continue that until we get this job done." Grassley's requested GAO report on the Office of Drug Safety will take several months.
Sen. Grassley Plans Legislation On Independence Of FDA Drug Safety Office
Finance Committee chair acknowledges he does not have enough votes for such legislation but says he is starting the "process of educating my colleagues" and "intends to continue that until we get this job done." Grassley's requested GAO report on the Office of Drug Safety will take several months.
FDA Oversight Of DTC Ads Will Be Examined By HHS Inspector General
The Inspector General will determine the effectiveness of FDA procedures for monitoring DTC ads and what actions are taken against companies with false and misleading ads, the IG’s fiscal 2005 work plan says. FDA’s handling of off-label drug promotions will also be studied.